Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry (v3.4.2) was added, and older notices including a funding-status message and Revision: v3.4.1 were deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check20 days agoChange DetectedRevision updated to v3.4.1 (replacing v3.4.0) and a site-wide notice about government funding; these are metadata changes and do not affect the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedThe new version adds a glossary display option, a color-coding legend for changes (green/red highlights), and updates the revision label to v3.4.0, replacing v3.3.4.SummaryDifference0.7%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added and the entry for v3.3.3 was removed in the study record history, which is a minor administrative update to the version history and does not affect study data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the site release notes/footer and removed HHS Vulnerability Disclosure and Revision: v3.3.2. These updates do not affect the trial record content or its history.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's revision history now includes a new entry for Revision v3.3.2. The entry for Revision v3.2.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.